Commodore Capital L.P., 10% Owner at Satsuma Pharmaceuticals, Inc. (STSA), bought 23,183 shares at $5.49 ($127K) on 2021-11-22, disclosed to the SEC on 2021-11-23.
Open-market purchase of $127k STSA by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.44 | 3,225 | $18K | 13.8% |
| 2 | $5.49 | 9,979 | $55K | 43.1% |
| 3 | $5.49 | 9,979 | $55K | 43.1% |
| Total | $5.48 avg | 23,183 | $127K | 100% |
| Filing → |
| VERA | BUY | 2023-06-22 | $13.6M | — | Filing → |
| ELVN | BUY | 2023-02-27 | $14K | — | Filing → |
| IMRA | BUY | 2023-02-23 | $284K | — | Filing → |